Semaglutide

Semaglutide

  • Brand: Bioamino Labs
  • Product Code: Semaglutide
  • Availability: In Stock
  • $89.00



Semaglut나ide (GLP-1) by Bioamino Labs — Advanced Glycemic & Weight Management Support

Achieve your metabolic goals with Semaglutide, a high-quality GLP-1 receptor agonist. Whether you are focused on weight loss or managing blood sugar levels during a bulking phase, this compound provides the precision and support necessary for your dietary and fitness regimens. Designed for athletes and those seeking weight management, this formula assists in maintaining healthy glycemic control.

Specifications

Active Substance Semaglutide (GLP-1)
Manufacturer Bioamino Labs
Formulation 2mg/vial + 2ml injection water
Active Half-Life 7 days
Classification Weight Loss / Weight Management

Description & Usage

Semaglutide is a potent agent that functions as a GLP-1 receptor agonist. It mimics the natural action of human incretin, assisting the pancreas in regulating insulin production. By interacting with the body's natural processes, it helps manage blood sugar levels, making it an excellent tool for weight loss or for maintaining metabolic balance during intensive bulking cycles.

This compound is ideal for individuals looking to avoid chronically high blood sugar levels, ensuring your underlying health remains supported even during periods of high caloric intake or intense training.

Recommended Dosage Schedule:

  • Weeks 1 through 4: 0.2나mg subcutaneously once a week
  • Weeks 5 through 8: 0.5mg subcutaneously once a week
  • Weeks 9 through 12: 1mg subcutaneously once a week
  • Weeks 13 through 16: 1.7mg subcutaneously once a week
  • Maintenance Dose: 2.4mg once a week from Week 17 onward

Dosing Considerations:

  • If dose escalation is not tolerated, consider delaying the increase for 4 weeks.
  • If the 2.4mg maintenance dose is not tolerated, you may temporarily decrease the dose to 1.7mg per week for a maximum of 4 weeks.
  • If the maintenance dose cannot be tolerated after 4 weeks, consider discontinuing therapy.